Position in EXEL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$774,199
+$167,563 QoQ
Shares Held
14,229
+0.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#370
of 751 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $2,648,282 across 5 Biotechnology names. EXEL ranks #2 (29.2% of the industry book) .
All Filings in EXEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $774,199 | 14,229 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $606,636 | 14,144 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $652,365 | 14,884 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $635,235 | 15,381 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $693,069 | 15,723 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $550,218 | 14,903 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $471,228 | 14,151 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $361,768 | 13,941 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $308,872 | 13,746 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $314,873 | 13,269 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $322,281 | 13,434 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $285,208 | 13,053 | Shares | Sole | 2023-10-31 | |
| 2021-09-30 | $279,661 | 13,229 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $185,078 | 10,158 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $229,469 | 10,158 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $200,077 | 9,969 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $226,407 | 9,260 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $234,361 | 9,872 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $269,716 | 15,663 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||